Pages

Thursday, January 12, 2017

FDA Law Blog-January 11, 2017 Drug Compounding: FDA Issues Final Guidance on Section 503A’s Individually Identified Prescription Requirement – With At Least Three Noteworthy Changes By Karla L. Palmer & James E. Valentine –

Post a Comment